Statistics

Total Visits

Views
Open label phase II clinical trial of orteronel (TAK700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The Greko II study-GETHI 20130160

Select a period of time:

Number of views in the range

Views
Open label phase II clinical trial of orteronel (TAK700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The Greko II study-GETHI 20130116

Views

Views
June 20252
July 202513
August 20250
September 20251
October 20250
November 20250
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
Brazil3
Austria1
Panama1
Poland1
Tunisia1
 

Top cities views

Views
Dallas1
Killeen1
Nutley1
Panama City1
Paraopeba1
Rio de Janeiro1
Santa Ana1
Somerville1
Tunis1
Vienna1